Neither bypass surgery nor stenting is categorically “worse.” They involve very different tradeoffs: bypass is a major open surgery with a longer, harder recovery, but it tends to produce better long-term results for people with severe or widespread blockages. Stenting is minimally invasive with a fast recovery, but it carries a higher chance of needing another procedure down the road. Which one is right depends on how many arteries are blocked, where the blockages are, and whether you have conditions like diabetes.
How the Two Procedures Compare
Stenting involves threading a thin catheter through a blood vessel in your wrist or groin up to the blocked artery in your heart, then inflating a tiny balloon to open it and leaving a small metal mesh tube (the stent) to hold it open. Most people go home the same day and recover quickly.
Bypass surgery is a different scale entirely. A surgeon opens your chest, takes a healthy blood vessel from your leg, arm, or chest wall, and grafts it around the blocked section to reroute blood flow. You’ll typically stay in the hospital for five days or longer, and full recovery takes six to eight weeks. For people with multiple blocked arteries, surgeons can bypass several blockages in a single operation, which is one of its key advantages.
Long-Term Survival and Heart Attack Risk
For people with complex, multi-vessel disease, bypass consistently outperforms stenting over the long run. A study of patients with three-vessel disease and heart failure found that at 10 years, 62.4% of bypass patients had died compared to 71.8% of stent patients. That’s a meaningful survival gap. Even more striking, heart attack readmission rates were dramatically lower after bypass: 3.2% versus 23.7% for stenting. The need for a repeat procedure was also far lower, at 6.4% versus 21.6%.
These numbers reflect patients with severe disease. For someone with a single blockage or less complex anatomy, the survival difference between the two procedures narrows considerably, and stenting often performs just as well.
The Repeat Procedure Problem
One of stenting’s biggest drawbacks is restenosis, where the treated artery gradually narrows again. Modern drug-eluting stents have improved significantly over earlier bare-metal designs, but even newer-generation stents see roughly 4 to 6% of patients needing another procedure on the same spot within five years. When you factor in patients with multiple stented arteries, the cumulative odds of returning for additional work go up.
Bypass grafts can fail too, but the rate of repeat revascularization is substantially lower. In the 10-year study of three-vessel disease patients, bypass patients needed a repeat procedure about one-third as often as stent patients.
Recovery and Short-Term Risk
This is where stenting clearly wins. Going home the same day versus spending a week in the hospital and then recovering for six to eight weeks is a massive difference in quality of life. For older patients or those with other health conditions that make major surgery risky, the lighter toll of stenting can tip the balance.
Bypass surgery carries a small but real risk of complications tied to the operation itself: infection, bleeding, and the effects of being on a heart-lung machine. Both procedures carry a similar risk of stroke, which is relatively low for each (around 2 to 3% over several years, with no significant difference between them in pooled trial data).
Outcomes for People With Diabetes
Diabetes changes the equation. People with diabetes and blockages in multiple arteries do notably better with bypass. A six-year study found that heart attack rates were three times higher after stenting compared to bypass (12.3% vs. 4.1%), and the rate of major cardiac events, including repeat procedures, was roughly double in the stent group (83.6% vs. 44.9%). Overall death rates were statistically similar between the two groups, but the burden of additional procedures and complications was much heavier on the stent side.
Diabetes accelerates the process that re-narrows arteries after stenting, which is a key reason bypass tends to hold up better in these patients.
How Doctors Decide Which to Recommend
Cardiologists use a scoring system called the SYNTAX score to rate the complexity of your blockages. It accounts for how many arteries are affected, where the blockages sit, and how difficult they’d be to treat. The score falls into three tiers:
- Low complexity (score under 22): Stenting and bypass produce similar outcomes. Stenting is often preferred because of the easier recovery.
- Intermediate complexity (score 23 to 32): Results are closer, and the decision often depends on individual factors like age, diabetes status, and overall health.
- High complexity (score 33 or above): Bypass is significantly better. Studies show that high-complexity patients treated with stents have worse outcomes across nearly every measure.
For blockages in the left main artery, the largest of the heart’s supply vessels, bypass has traditionally been the standard. More recent data suggests stenting can be a reasonable alternative for patients with low or intermediate complexity scores, but bypass remains preferred for high-risk anatomy.
Symptom Relief and Quality of Life
If your main concern is chest pain (angina), both procedures offer meaningful relief, and both outperform medication alone for symptom control. The landmark ISCHEMIA trial, funded by the NIH, found that invasive procedures provided “impressive, sustainable improvement” in symptoms, daily functioning, and quality of life for up to four years. That said, this benefit only showed up in the roughly two-thirds of patients who actually had chest pain before the procedure. Patients without symptoms saw no quality-of-life advantage from either intervention.
For people with stable heart disease and no chest pain, medication and lifestyle changes alone were just as effective at preventing heart attacks and death as stenting or bypass. This is an important point: not everyone with a blockage needs a procedure at all.
Medications After Each Procedure
Both procedures require blood-thinning medications afterward, but the regimen differs. After stenting, you’ll take two antiplatelet drugs (typically aspirin plus a second agent) for 6 to 12 months to prevent blood clots from forming inside the stent. Missing doses during this window significantly increases the risk of a sudden clot.
After bypass, aspirin is standard long-term. Some patients also receive a second antiplatelet drug for up to a year, particularly if the surgery was performed after a heart attack. The dual-drug period after bypass may help prevent graft failure, but it also increases bleeding risk, so the duration is tailored to the individual.
Which Is “Worse” Depends on Your Situation
If “worse” means a harder physical experience, bypass is unquestionably tougher. It’s major surgery with a long recovery. If “worse” means a higher chance of needing another procedure or having a heart attack years later, stenting carries that risk for patients with complex, multi-vessel disease or diabetes. For a single, straightforward blockage in an otherwise healthy person, stenting performs well and spares you a major operation. For widespread disease, bypass pays off its difficult recovery with durability that stenting has not matched.